Design and Synthesis of a (N-Alkylaminoalkyl-Substituted)Arylalkenylamide Drug Discovery Library
Journal:
Letters in Drug Design & Discovery
Volume:
4
Page:
605-610
Author(s):
M. Urbano, S. Collina, D. Rossi, A. Carnevale Baraglia, S. Alcaro, A. Artese and O. Azzolina
Synthetic Approaches to the 2006 New Drugs
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
1255-1269
Author(s):
Kevin K.-C. Liu, Subas M. Sakya and Jin Li
Possibilities of Two-Dimensional Gel Electrophoresis in the Understanding of Human Disease
Journal:
Current Proteomics
Volume:
4
Page:
187-197
Author(s):
Jose Luis Lopez and Jose Bermudez-Crespo
Computational Methods and Algorithms for Mass-Spectrometry Based Differential Proteomics
Journal:
Current Proteomics
Volume:
4
Page:
223-234
Author(s):
Seferina Mavroudi, Stergios Papadimitriou, Sophia Kossida, Spyridon D. Likothanassis and Antonia Vlahou
Relevance of Protein Isoforms in Proteomic Studies
Journal:
Current Proteomics
Volume:
4
Page:
235-252
Author(s):
Maria Paez de la Cadena, Ana M. Rodriguez-Pineiro, Paula Alvarez-Chaver, Vicenta S. Martinez-Zorzano and Francisco J. Rodriguez-Berrocal
Prognostic and Predictive Markers in Colorectal Cancer – The Role of New Genomic Technologies
Journal:
Current Pharmacogenomics
Volume:
5
Page:
255-261
Author(s):
Vicky M. Coyle, Wendy L. Allen, Daniel B. Longley and Patrick G. Johnston
Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Journal:
Current Pharmacogenomics
Volume:
5
Page:
280-291
Author(s):
Bernard Friedenson
Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
594-611
Author(s):
Rosalind H. Gunby, Elisa Sala, Carmen J. Tartari, Miriam Puttini, Carlo Gambacorti-Passerini and Luca Mologni
Src Family Nonreceptor Tyrosine Kinases as Molecular Targets for Cancer Therapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
651-659
Author(s):
Faye M. Johnson and Gary E. Gallick
Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Journal:
Current Enzyme Inhibition
Volume:
3
Page:
273-283
Author(s):
Carlo Smirne, Anna Carbone, Tiziana Scirelli and Graziella Bellone